Cargando…

Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa

BACKGROUND: Flow cytometric immunophenotyping is well established for the diagnosis of haematological neoplasms. New commercially available systems offer fixed, pre-aliquoted multi-parameter analysis to simplify sample preparation and standardise data analysis. OBJECTIVE: The Beckman Coulter (BC) Cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Glencross, Deborah K., Swart, Leanne, Pretorius, Melanie, Lawrie, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350555/
https://www.ncbi.nlm.nih.gov/pubmed/35937760
http://dx.doi.org/10.4102/ajlm.v11i1.1458
_version_ 1784762242894397440
author Glencross, Deborah K.
Swart, Leanne
Pretorius, Melanie
Lawrie, Denise
author_facet Glencross, Deborah K.
Swart, Leanne
Pretorius, Melanie
Lawrie, Denise
author_sort Glencross, Deborah K.
collection PubMed
description BACKGROUND: Flow cytometric immunophenotyping is well established for the diagnosis of haematological neoplasms. New commercially available systems offer fixed, pre-aliquoted multi-parameter analysis to simplify sample preparation and standardise data analysis. OBJECTIVE: The Beckman Coulter (BC) ClearLLab™ 10C (4-tube) system was evaluated against an existing laboratory developed test (LDT). METHODS: Peripheral blood and bone marrow aspirates (n = 101), tested between August 2019 and November 2019 at an academic pathology laboratory in Johannesburg, South Africa, were analysed. Following daily instrument quality control, samples were prepared for LDT (using > 20 2–4-colour in-house panels and an extensive liquid monoclonal reagent repertoire) or ClearLLab 10C, and respectively analysed using in-house protocols on a Becton Dickinson FACSCalibur, or manufacturer-directed protocols on a BC Navios. Becton Dickinson Paint-a-Gate or BC Kaluza C software facilitated data interpretation. Diagnostic accuracy (concordance) was established by calculating sensitivity and specificity outcomes. RESULTS: Excellent agreement (clinical diagnostic concordance) with 100% specificity and sensitivity was established between LDT and ClearLLab 10C in 67 patients with a haematological neoplasm and 34 participants with no haematological disease. Similar acceptable diagnostic concordance (97%) was noted when comparing ClearLLab 10C to clinicopathological outcomes. Additionally, the ClearLLab 10C panels, analysed with Kaluza C software, enabled simultaneous discrimination of disease and concurrent background myeloid and lymphoid haematological populations, including assessing stages of maturation or sub-populations. CONCLUSION: ClearLLab 10C panels provide excellent agreement to existing LDTs and may reliably be used for immunophenotyping of haematological neoplasms, simplifying and standardising sample preparation and data acquisition.
format Online
Article
Text
id pubmed-9350555
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-93505552022-08-05 Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa Glencross, Deborah K. Swart, Leanne Pretorius, Melanie Lawrie, Denise Afr J Lab Med Original Research BACKGROUND: Flow cytometric immunophenotyping is well established for the diagnosis of haematological neoplasms. New commercially available systems offer fixed, pre-aliquoted multi-parameter analysis to simplify sample preparation and standardise data analysis. OBJECTIVE: The Beckman Coulter (BC) ClearLLab™ 10C (4-tube) system was evaluated against an existing laboratory developed test (LDT). METHODS: Peripheral blood and bone marrow aspirates (n = 101), tested between August 2019 and November 2019 at an academic pathology laboratory in Johannesburg, South Africa, were analysed. Following daily instrument quality control, samples were prepared for LDT (using > 20 2–4-colour in-house panels and an extensive liquid monoclonal reagent repertoire) or ClearLLab 10C, and respectively analysed using in-house protocols on a Becton Dickinson FACSCalibur, or manufacturer-directed protocols on a BC Navios. Becton Dickinson Paint-a-Gate or BC Kaluza C software facilitated data interpretation. Diagnostic accuracy (concordance) was established by calculating sensitivity and specificity outcomes. RESULTS: Excellent agreement (clinical diagnostic concordance) with 100% specificity and sensitivity was established between LDT and ClearLLab 10C in 67 patients with a haematological neoplasm and 34 participants with no haematological disease. Similar acceptable diagnostic concordance (97%) was noted when comparing ClearLLab 10C to clinicopathological outcomes. Additionally, the ClearLLab 10C panels, analysed with Kaluza C software, enabled simultaneous discrimination of disease and concurrent background myeloid and lymphoid haematological populations, including assessing stages of maturation or sub-populations. CONCLUSION: ClearLLab 10C panels provide excellent agreement to existing LDTs and may reliably be used for immunophenotyping of haematological neoplasms, simplifying and standardising sample preparation and data acquisition. AOSIS 2022-07-15 /pmc/articles/PMC9350555/ /pubmed/35937760 http://dx.doi.org/10.4102/ajlm.v11i1.1458 Text en © 2022. The Authors https://creativecommons.org/licenses/by/4.0/Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Original Research
Glencross, Deborah K.
Swart, Leanne
Pretorius, Melanie
Lawrie, Denise
Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa
title Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa
title_full Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa
title_fullStr Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa
title_full_unstemmed Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa
title_short Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa
title_sort evaluation of fixed-panel, multicolour clearllab 10c at an academic flow cytometry laboratory in johannesburg, south africa
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350555/
https://www.ncbi.nlm.nih.gov/pubmed/35937760
http://dx.doi.org/10.4102/ajlm.v11i1.1458
work_keys_str_mv AT glencrossdeborahk evaluationoffixedpanelmulticolourclearllab10catanacademicflowcytometrylaboratoryinjohannesburgsouthafrica
AT swartleanne evaluationoffixedpanelmulticolourclearllab10catanacademicflowcytometrylaboratoryinjohannesburgsouthafrica
AT pretoriusmelanie evaluationoffixedpanelmulticolourclearllab10catanacademicflowcytometrylaboratoryinjohannesburgsouthafrica
AT lawriedenise evaluationoffixedpanelmulticolourclearllab10catanacademicflowcytometrylaboratoryinjohannesburgsouthafrica